Real-World Study of Ceftazidime Avibactam in China

Stopped The study was prematurely discontinued due to slow enrollment and strategic considerations. This decision was not based on any safety or efficacy concerns.

Conditions

• Hospital Acquired Pneumonia
• Ventilator Acquired Pneumonia
• Complicated Intra Abdominal Infections

Interventions

• DRUG: ceftazidime avibactam group

Sponsor

Pfizer